KEAP1 and Parkinson disease: In conclusion, taken together with several predecessor studies, our data provide further supporting evidence to highlight the role of NRF2/Keap1 pathway in PD, and underscores the relevance of modulating the activity of this pathway for potential therapies in PD and related diseases.